Kristin P. Hutchins, MHA
President and Chief Executive Officer
Kristin P. Hutchins leads GuideStar’s expert team in the development and management of comprehensive clinical research programs for hospitals, health systems and physician practices. Her mission is to deliver clinical trial management services to clients with a precision of execution, efficiency and operational excellence, while enhancing the client’s strategic business growth, and still respecting the client’s individual needs and goals.
Christine A. Miller, CPA
Chief Financial Officer
Christine A. Miller administers all aspects of financial reporting, cash management, budgeting and forecasting for GuideStar. She provides decision support to strategic planning, and imposes financial discipline and rigor on the company’s operations.
Gregory E. Vaughan
Chief Technology Officer
Gregory E. Vaughan has spent his career at the leading edge of technological innovation and administration. He has served in technology positions across a diverse set of industries, providing him with a broad knowledge base and experience in the technology field. Over the past fifteen years, Greg has focused his efforts in the area of healthcare technology.
Rhonda J. Paz, PhD, CRCP
Chief Operating Officer
In her role as Chief Operating Officer, Dr. Paz is responsible for strategizing and implementing new service lines and products as well as the formation of expert operational units to support the variety of service needs of client research sites. She oversees all staff units, ensuring that operating goals and performance metrics are achieved.
Shirley Trainor-Thomas, MHSA
Chief Strategy Officer
Shirley Trainor-Thomas has spent her entire career in the healthcare field focusing specifically on clinical research for nearly the last decade. She currently serves as Chief Marketing Officer of GuideStar. With experience in both clinical trials operations and hospital administration, Ms. Trainor-Thomas focuses on developing solid relationships with physicians and hospital leadership, as well as the pharmaceutical, biotech and device industries.